Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Iaconis

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Antiviral Research|August 10, 2023
Diketo acid inhibitors of nsp13 of SARS-CoV-2 block viral replicationAngela Corona, Valentina Noemi Madia, Riccardo De Santis, et al.
ACS Pharmacology & Translational Science|January 16, 2025
Thiol-Reactive or Redox-Active: Revising a Repurposing Screen Led to a New Invalidation Pipeline and Identified a True Noncovalent Inhibitor Against Papain-like Protease from SARS-CoV-2Maria Kuzikov, Stefano Morasso, Jeanette Reinshagen, et al.
Antiviral Research|February 20, 2025
The efficiency of high-throughput screening (HTS) and in-silico data analysis during medical emergencies: Identification of effective antiviral 3CLpro inhibitorsDebora Zian, Daniela Iaconis, Simone Nenci, et al.
Cell Death & Disease|May 25, 2022
Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variantsDaniela Iaconis, Licia Bordi, Giulia Matusali, et al.
Cell Death & Disease|May 25, 2022
Paclitaxel binds and activates C5aR1: A new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactionsLaura Brandolini, Michele d'Angelo, Rubina Novelli, et al.
Scientific Data|July 13, 2022
Cytopathic SARS-CoV-2 screening on VERO-E6 cells in a large-scale repurposing effortAndrea Zaliani, Laura Vangeel, Jeanette Reinshagen, et al.
ACS Pharmacology & Translational Science|March 15, 2022
Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing ScreenMaria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2022
The SARS-CoV-2 spike protein binds and modulates estrogen receptorsOscar Solis, Andrea R Beccari, Daniela Iaconis, et al.
Science Advances|November 30, 2022
The SARS-CoV-2 spike protein binds and modulates estrogen receptorsOscar Solis, Andrea R Beccari, Daniela Iaconis, et al.
Nature Communications|May 14, 2016
An organelle-specific protein landscape identifies novel diseases and molecular mechanismsKarsten Boldt, Jeroen van Reeuwijk, Qianhao Lu, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Antiviral Research|August 10, 2023
Diketo acid inhibitors of nsp13 of SARS-CoV-2 block viral replicationAngela Corona, Valentina Noemi Madia, Riccardo De Santis, et al.
ACS Pharmacology & Translational Science|January 16, 2025
Thiol-Reactive or Redox-Active: Revising a Repurposing Screen Led to a New Invalidation Pipeline and Identified a True Noncovalent Inhibitor Against Papain-like Protease from SARS-CoV-2Maria Kuzikov, Stefano Morasso, Jeanette Reinshagen, et al.
Antiviral Research|February 20, 2025
The efficiency of high-throughput screening (HTS) and in-silico data analysis during medical emergencies: Identification of effective antiviral 3CLpro inhibitorsDebora Zian, Daniela Iaconis, Simone Nenci, et al.
Cell Death & Disease|May 25, 2022
Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variantsDaniela Iaconis, Licia Bordi, Giulia Matusali, et al.
Cell Death & Disease|May 25, 2022
Paclitaxel binds and activates C5aR1: A new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactionsLaura Brandolini, Michele d'Angelo, Rubina Novelli, et al.
Scientific Data|July 13, 2022
Cytopathic SARS-CoV-2 screening on VERO-E6 cells in a large-scale repurposing effortAndrea Zaliani, Laura Vangeel, Jeanette Reinshagen, et al.
ACS Pharmacology & Translational Science|March 15, 2022
Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing ScreenMaria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2022
The SARS-CoV-2 spike protein binds and modulates estrogen receptorsOscar Solis, Andrea R Beccari, Daniela Iaconis, et al.
Science Advances|November 30, 2022
The SARS-CoV-2 spike protein binds and modulates estrogen receptorsOscar Solis, Andrea R Beccari, Daniela Iaconis, et al.
Nature Communications|May 14, 2016
An organelle-specific protein landscape identifies novel diseases and molecular mechanismsKarsten Boldt, Jeroen van Reeuwijk, Qianhao Lu, et al.
Pageof 3